This is a few years old, but still very relevant. It’s from a speech by former FDA Commissioner Scott Gottlieb on March 7, 2018 titled “Capturing the Benefits of Competition for Patients“
Patients shouldn’t be penalized by their biology if they need a drug that isn’t on formulary. Patient
